WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric ...
The most suitable insulin administration method varies from person to person. A healthcare professional can help someone determine the best type for them. Sliding scale insulin therapy involves ...
Two counties in the Charlotte area have filed lawsuits in the last few weeks over the price of insulin. Gaston County and ...
Some thrillseekers climb 46 high peaks, but a Corinth teen has a different achievement in mind. Conley Baldwin has decided to snowboard 30,000 vertical feet on 20 different mountains in the name ...
“Our internal and external experts all believe that the implementational time frame, while not as fast as we had hoped, are ...
Similar to Ellison’s settlement in January, the federal Inflation Reduction Act capped out-of-pocket costs on insulin at $35 per month for those enrolled in Medicare. The Act could be subject to ...
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
Interesting Engineering on MSN4d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentThe FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback